141.35
price down icon0.72%   -1.02
 
loading

Biogen Inc Aktie (BIIB) Neueste Nachrichten

pulisher
02:31 AM

Biogen (BIIB) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat

02:31 AM
pulisher
Feb 08, 2025

Why Biogen Inc. (BIIB) Is Among the Best Healthcare Stocks To Buy According to Analysts - Yahoo Finance

Feb 08, 2025
pulisher
Feb 08, 2025

Biogen Inc. (NASDAQ:BIIB) Stake Boosted by Mirae Asset Global Investments Co. Ltd. - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Greenleaf Trust Has $775,000 Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Win Advisors Inc. Buys New Shares in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Feb 08, 2025
pulisher
Feb 07, 2025

Biogen (BIIB) to Release Earnings on Tuesday - MarketBeat

Feb 07, 2025
pulisher
Feb 07, 2025

12 Best Healthcare Stocks to Buy According to Analysts - Insider Monkey

Feb 07, 2025
pulisher
Feb 07, 2025

As US Sales of Leqembi Lag, Eisai Eyes SubQ Approvals - BioSpace

Feb 07, 2025
pulisher
Feb 07, 2025

Seeking Clues to Biogen (BIIB) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance

Feb 07, 2025
pulisher
Feb 06, 2025

IMMINENT BIIB DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit - ACCESS Newswire

Feb 06, 2025
pulisher
Feb 06, 2025

Biogen Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Feb 06, 2025
pulisher
Feb 06, 2025

FY2024 EPS Estimates for Biogen Reduced by Cantor Fitzgerald - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Retirement Systems of Alabama Purchases 154,062 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Feb 06, 2025
pulisher
Feb 05, 2025

Biogen Inc. stock outperforms competitors on strong trading day - MarketWatch

Feb 05, 2025
pulisher
Feb 05, 2025

Biogen Stock Down on Regulatory Update in the EU for Alzheimer's Drug - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

Cantor Fitzgerald cuts Biogen stock price target to $206 By Investing.com - Investing.com South Africa

Feb 05, 2025
pulisher
Feb 05, 2025

Cantor Fitzgerald cuts Biogen stock price target to $206 - Investing.com

Feb 05, 2025
pulisher
Feb 05, 2025

Biogen Inc. (BIIB) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Feb 05, 2025
pulisher
Feb 05, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Old North State Wealth Management LLC - MarketBeat

Feb 05, 2025
pulisher
Feb 05, 2025

abrdn plc Reduces Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

Judge Explains Biogen Class Cert. Ruling After 1st Circ. Order - Law360

Feb 04, 2025
pulisher
Feb 04, 2025

Global Water Flavouring Drops Market Poised for Substantial Growth, Projected to Reach USD 73.91 Billion by 2035 | Future Market Insights, Inc. - GlobeNewswire Inc.

Feb 04, 2025
pulisher
Feb 04, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Sold by China Universal Asset Management Co. Ltd. - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Purchased by Forsta AP Fonden - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

FY2025 EPS Estimates for Biogen Lowered by Leerink Partnrs - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Sumitomo Life Insurance Co. Trims Stock Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Cairn Investment Group Inc. Sells 3,153 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

One week after Netherlands defeat Biogen takes the win in Germany - JUVE Patent

Feb 03, 2025
pulisher
Feb 03, 2025

BRIEF—EC calls for update on regulatory review of lecanemab - The Pharma Letter

Feb 03, 2025
pulisher
Feb 03, 2025

Robeco Institutional Asset Management B.V. Has $62.43 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

Tardive Dyskinesia Treatment Market Report Analysis - openPR

Feb 02, 2025
pulisher
Feb 02, 2025

(BIIB) Investment Analysis and Advice - Stock Traders Daily

Feb 02, 2025
pulisher
Feb 02, 2025

FY2027 EPS Estimates for Biogen Reduced by Leerink Partnrs - MarketBeat

Feb 02, 2025
pulisher
Feb 02, 2025

Why Are Analysts Bullish on Biogen Inc. (BIIB) Now? - MSN

Feb 02, 2025
pulisher
Feb 02, 2025

Smith Group Asset Management LLC Purchases New Shares in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Feb 02, 2025
pulisher
Feb 02, 2025

12 Best S&P 500 Stocks to Invest in According to Analysts - Insider Monkey

Feb 02, 2025
pulisher
Feb 01, 2025

Kirr Marbach & Co. LLC IN Sells 4,578 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

Citigroup Has Lowered Expectations for Biogen (NASDAQ:BIIB) Stock Price - MarketBeat

Jan 31, 2025
pulisher
Jan 31, 2025

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union - GlobeNewswire

Jan 31, 2025
pulisher
Jan 31, 2025

Biogen Inc. stock underperforms Friday when compared to competitors - MarketWatch

Jan 31, 2025
pulisher
Jan 31, 2025

Leqembi review stalls again at European regulator - BioWorld Online

Jan 31, 2025
pulisher
Jan 31, 2025

Biogen Stock Price | BIIB Stock Quote, News, and History - Markets Insider

Jan 31, 2025
pulisher
Jan 31, 2025

Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok - Benzinga

Jan 31, 2025
pulisher
Jan 31, 2025

Europe to review safety data for Eisai-Biogen Alzheimer's drug - Reuters

Jan 31, 2025
pulisher
Jan 31, 2025

Biogen, Eisai Say EU Panel Set to Discuss Additional Safety Data on Lecanemab -January 31, 2025 at 08:10 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

EU to Weigh New Safety Data on Biogen, Eisai Alzheimer’s Drug - Bloomberg

Jan 31, 2025
pulisher
Jan 31, 2025

Europe to review safety data for Eisai-Biogen Alzheimer’s drug - 1470 & 100.3 WMBD

Jan 31, 2025
pulisher
Jan 31, 2025

Biogen, Eisai: EC Asks CHMP to Take Another Look at Leqembi - MarketWatch

Jan 31, 2025
pulisher
Jan 31, 2025

Biogen stock in focus as Alzheimer’s drug review delayed (BIIB) - Seeking Alpha

Jan 31, 2025
pulisher
Jan 31, 2025

Europe to review safety data for Eisai-Biogen Alzheimer's drug -January 31, 2025 at 07:05 am EST - Marketscreener.com

Jan 31, 2025
pulisher
Jan 31, 2025

Rx Rundown: Merck, Biogen, Pfizer and more - MM+M Online

Jan 31, 2025
pulisher
Jan 31, 2025

European Commission Demands Fresh Safety Analysis of Breakthrough Alzheimer's Treatment - StockTitan

Jan 31, 2025
pulisher
Jan 30, 2025

Amyotrophic Lateral Sclerosis (ALS) Market Future Prospects, - openPR

Jan 30, 2025
pulisher
Jan 30, 2025

March 14th Options Now Available For Biogen (BIIB) - Nasdaq

Jan 30, 2025
pulisher
Jan 30, 2025

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics - Yahoo Finance

Jan 30, 2025
$96.04
price down icon 2.04%
drug_manufacturers_general SNY
$53.35
price up icon 0.91%
drug_manufacturers_general PFE
$25.74
price down icon 0.35%
$293.54
price down icon 1.42%
drug_manufacturers_general NVS
$106.26
price down icon 0.67%
drug_manufacturers_general MRK
$87.28
price down icon 0.87%
Kapitalisierung:     |  Volumen (24h):